Benzinga | Oct 19, 2020 07:09AM EDT

Morgan Stanley Initiates Coverage On GoodRx Holdings with Overweight Rating, Announces Price Target of $57

Morgan Stanley initiates coverage on GoodRx Holdings (NASDAQ:GDRX) with a Overweight rating and announces Price Target of $57.